Company Overview of QR Pharma, Inc.
QR Pharma, Inc. develops drugs for the treatment of mild cognitive impairment, Alzheimer's, Parkinson's, and Down Syndrome diseases. It offers Posiphen compound for mild cognitive impairment and early stage Alzheimer's disease; and Bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. QR Pharma, Inc. was founded in 2008 and is based in Radnor, Pennsylvania.
259 Radnor Chester Road
Radnor, PA 19087
Founded in 2008
Key Executives for QR Pharma, Inc.
Similar Private Companies By Industry
|Biosynexus Incorporated||United States|
|Aponia Laboratories Inc.||United States|
|Velius, LLC||United States|
|CardioPharma, Inc.||United States|
|Acretia, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact QR Pharma, Inc., please visit www.qrpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.